Viewing nowClopijen Tablets (Clopidogrel Bisulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Celix Co., Ltd.

MFDS item code 200501667 · Notified 2005.10.26 · Insurance code 646201930
Improvement of atherosclerotic symptoms and acute coronary syndrome symptoms; prevention of blood clots in atrial fibrillation
This medication is used for individuals with vascular health issues. It helps improve symptoms of atherosclerotic diseases such as ischemic stroke, myocardial infarction, and peripheral arterial disease. It also reduces the risk of death, myocardial infarction, and stroke due to cardiovascular anomalies in patients with acute coronary syndrome, especially those experiencing unstable angina or non-Q-wave myocardial infarction. Patients who have undergone or are scheduled for coronary interventional procedures or coronary artery bypass surgery can also benefit from this medication. Additionally, it reduces the risk of stroke and thromboembolism in patients with atrial fibrillation who have one or more vascular risk factors, and for whom vitamin K antagonists are not suitable. Overall, this medication is used to reduce the risk of atherosclerotic symptoms and complications, thereby improving health.
1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the day treatment with this medicine is initiated, start with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. In this case, aspirin 75 ~ 325 mg must be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer this medicine 75 mg orally once daily. In this case, aspirin 75 ~ 100 mg must be administered concomitantly with this medicine once daily. This medicine may be administered without regard to food.
This medication prevents platelets from aggregating, helping the blood to flow more freely. This drug must be activated in the liver by a specific enzyme (CYP2C19) to be effective, and individuals with genetically reduced enzyme function may find the effectiveness of the medication diminished and require special caution. During treatment, there may be an increased risk of bleeding, which means that bleeding may take longer to stop than usual. If bleeding occurs or worsens, or if it persists for a long time, consult a doctor immediately. It should not be administered to patients with bleeding tendencies, significant liver or kidney damage, nursing mothers, or patients with certain genetic disorders such as lactose intolerance. Patients who are about to undergo surgery or invasive procedures should stop taking this medication 5 to 7 days before the procedure, and caution is particularly important when taking it with other drugs that increase bleeding risk. This medication may increase the risk of bleeding when taken with other drugs that affect blood coagulation, especially aspirin, warfarin, non-steroidal anti-inflammatory drugs, and selective serotonin reuptake inhibitors (SSRIs), so consult a doctor. Rarely, this medication might cause a serious side effect of a rapid decrease in the number of white blood cells in the blood, so if there are symptoms of fever or infection, visit a hospital immediately. Additionally, if allergic reactions such as skin rash, itching, or difficulty breathing occur, discontinue the medication immediately and consult a physician. The impact on the fetus during pregnancy is unclear, but in emergency situations such as myocardial infarction or stroke, treatment should not be delayed, and it is recommended to stop medication before delivery to reduce the risk of bleeding. For nursing mothers, it is important to carefully decide whether to continue breastfeeding or discontinue the medication, as this drug may be excreted in breast milk. The safety and effectiveness in children have not been established, and caution is necessary in elderly patients or those with impaired kidney or liver function, as the risk of bleeding may be higher, requiring dosage adjustments and careful monitoring. In the case of overdose, the risk of bleeding significantly increases, and since there is no specific antidote, treatment for bleeding may require platelet transfusions or similar interventions. This medication should be stored out of reach of children, and transferring it to another container may affect its quality.
Hemorrhage, gastrointestinal bleeding, purpura, contusion, hematoma, epistaxis, hematuria, intraocular hemorrhage, intracranial hemorrhage, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, depression, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, decreased motor function, tremor, voice disorder, abnormal gait, hyperkinesis, ataxia, sensory disturbance, insomnia, depression, amnesia, anxiety, lethargy, abnormal thoughts, abnormal behavior, arthralgia, myalgia, low back pain, weight loss, weight gain, facial flushing, weakness, rigidity, facial edema, syncope, hematochezia, cerebral hemorrhage, gingival bleeding, anemia, pneumonia, sinusitis, visual disturbance, visual field defect, dry eye syndrome, transient blindness, congestion, tinnitus, urinary disturbance, polyuria, hypoglycemia, hyperuricemia, elevated liver enzymes, increased ALT, abnormal liver function, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, gynecomastia, elevated prostate-specific antigen, cholecystitis, hematemesis, spinal hematoma, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, herpes zoster, erythematous rash, maculopapular rash, urticaria, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eosinophilia, drug rash, eczema, lichen planus, glomerulopathy, gynecomastia, fever, abnormal liver function tests, elevated blood creatinine, allergic symptoms, ischemic necrosis, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, pulmonary hemorrhage, thrombocytopenia, hypochromic anemia, leukemia, leukopenia, eosinophilia, menorrhagia, hemothorax, renal function abnormality, acute renal failure, confusion, hallucinations, taste disturbance, taste loss, angioedema, anaphylactoid reaction, serum sickness, Kounis syndrome, insulin autoimmune syndrome, confusion, hallucinations, taste disturbance, taste loss, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, herpes zoster, erythematous rash, maculopapular rash, urticaria, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome with eosinophilia and systemic symptoms, eczema, lichen planus, arthralgia, arthritis, myalgia, glomerulopathy, gynecomastia, fever, abnormal liver function tests, elevated blood creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safest to keep it at room temperature between 1 degree and 30 degrees Celsius.
Pink round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Celix Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.